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Skin	represents	an	important	route	of	exposure	and	determining	whether	such	
incidental	or	intentional	exposure	poses	a	risk	to	human	health	requires	
consideration	of	temporal	concentration,	in	addition	to	assessing	the	chemical’s	
intrinsic	hazard.	In	order	to	elicit	a	toxic	response	in	vivo	the	chemical	must	
reach	its	site	of	action	in	sufficient	concentration,	as	determined	by	its	
absorption,	distribution,	metabolism	and	elimination	(ADME)	profile.	Whilst	
absorption	and	distribution	into	and	through	skin	layers	have	been	studied	for	
decades,	only	more	recently	has	skin	metabolism	become	a	subject	of	intense	
research,	now	recognised	as	playing	a	key	role	in	both	toxification	and	
detoxification	processes.	EU	directives	on	animal	use	for	toxicity	testing	and	the	
lack	of	human	skin	for	research	has	prompted	an	increase	in	the	use	of	tissue-	
engineered	human	skin	models.	These	models	are	histologically	similar	to	
human	skin	and	express	metabolising	enzymes	making	them	ideal	in	vitro	tools	
for	toxicity	testing.	In	this	talk,	I	will	discuss	how	the	use	of	these	models	in	
combination	with	in	silico	tools	may	be	used	to	resolve	a	significant	challenge	in	
predicting	toxicity	following	dermal	exposure.	I	will	highlight	how	in	vitro	data	
can	be	used	to	drive	novel	multiscale	mathematical	models	that	predict	the	
kinetics	of	xenobiotic	metabolising	enzymes,	their	transdermal	distribution,	
spatiotemporal	metabolite	distributions	and	whole	body	systemic	exposures	for	
a	wide	range	of	chemical	structures.	The	ability	to	predict	metabolism	in	the	skin	
would	significantly	aid	risk	assessment	and	shorten	the	length	of	time	from	
discovery	to	patient	benefit.	
